INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $241,000 | -81.7% | 70,431 | -84.0% | 0.03% | -82.3% |
| Q2 2021 | $1,320,000 | -22.9% | 441,473 | -16.7% | 0.19% | -44.1% |
| Q1 2021 | $1,712,000 | +5606.7% | 530,000 | +2255.6% | 0.33% | +16550.0% |
| Q2 2016 | $30,000 | -88.2% | 22,500 | -25.0% | 0.00% | -80.0% |
| Q3 2015 | $254,000 | +247.9% | 30,000 | +451.7% | 0.01% | +233.3% |
| Q3 2014 | $73,000 | -92.5% | 5,438 | -92.2% | 0.00% | -95.2% |
| Q4 2013 | $967,000 | +104.0% | 70,000 | +139.8% | 0.06% | +93.8% |
| Q2 2013 | $474,000 | – | 29,188 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
| Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
| QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
| BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
| Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
| Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
| Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
| OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
| Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |